ADC biotech brings to­tal Se­ries A raise to $89M+; Take­da hands $40M mile­stone to Ar­row­head

Dan­ish biotech Ad­cen­do has tacked on an ad­di­tion­al $33.8 mil­lion to a Se­ries A it raised a few years ago.

Ad­cen­do had orig­i­nal­ly raised a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA